Philips reports Q3 2026 results, order intake up, margin expansion, and maintains FY26 outlook
Philips announced Q3 2026 comparable order intake up 8% and comparable sales up 3%, with group sales around €4.4 billion. Adjusted EBITA margin improved to 13.0% and adjusted EBITDA rose to €772 million, while net income dropped to €28 million due to a €288 million Respironics DOJ settlement provision. The company reiterated its FY‑2026 guidance of 3‑4.5% comparable sales growth and an adjusted EBITA margin of 13.5‑14%.
Why it matters
The reaffirmed FY‑2026 outlook suggests continued revenue growth and margin expansion, which may support Philips’ cash‑flow generation and dividend capacity (the company’s statement). The net‑income decline is a one‑off item and does not affect the operating performance outlook.
Key facts
- 1Comparable order intake grew 8% in Q3 2026 finanznachrichten.de
- 2Comparable sales grew 3% in Q3 2026 finanznachrichten.de
- 3Adjusted EBITA margin rose 70 basis points to 13.0% finanznachrichten.de
- 4Net income fell to €28 million in Q3 2026 rttnews.com
- 5Adjusted EBITDA reached €772 million in Q3 2026 rttnews.com
- 6Philips reaffirmed its FY‑2026 outlook of 3‑4.5% comparable sales growth and adjusted EBITA margin of 13.5‑14% investing.com
Summary written by AlphAI AI Desk from 5 of 5 sources. Not investment advice. Figures are as stated by the linked sources.